Abstract
Erythritol is a sugar alcohol that is widely used as a natural sugar substitute. Thus, the safety of its usage is very important. In the present study, short-term genotoxicity assays were conducted to evaluate the potential genotoxic effects of erythritol. According to the OECD test guidelines, the maximum test dose was 5,000 µg/plate in bacterial reverse mutation tests, 5,000 µg/ml in cell-based assays, and 5,000 mg/kg for in vivo testing. An Ames test did not reveal any positive results. No clastogenicity was observed in a chromosomal aberration test with CHL cells or an in vitro micronucleus test with L5178Y tk+/- cells. Erythritol induced a marginal increase of DNA damage at two high doses by 24 hr of exposure in a comet assay using L5178Y tk+/- cells. Additionally, in vivo micronucleus tests clearly demonstrated that oral administration of erythritol did not induce micronuclei formation of the bone marrow cells of male ICR mice. Taken together, our results indicate that erythritol is not mutagenic to bacterial cells and does not cause chromosomal damage in mammalian cells either in vitro or in vivo.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Shindou, T., Sasaki, Y., Miki, H., Eguchi, T., Hagiwara, K. and Ichikawa, T. (1988) Determination of erythritol in fermented foods by high performance liquid chromatography. Shokuhin Eiseigaku Zasshi, 29, 419–422.
Goossens, J. and Röper, H. (1994) Erythritol: A new bulk sweetener. Int. Food Ingredients, 1/2, 27–33.
Munro, I.C., Berndt, W.O., Borzelleca, J.F., Flamm, G., Lynch, B.S., Kennepohl, E., Bär, E.A. and Modderman, J. (1998) Erythritol: an interpretive summary of biochemical, metabolic, toxicological and clinical data. Food Chem. Toxicol., 36, 1139–1174.
Arrigoni, E., Brouns, F. and Amadò, R. (2005) Human gut microbiota does not ferment erythritol. Br. J. Nutr., 94, 643–646.
Hino, H., Kasai, S., Hattori, N. and Kenjo, K. (2000) A case of allergic urticaria caused by erythritol. J. Dermatol., 27, 163–165.
FDA/CFSAN. (2001) Agency Response Letter: GRAS Notice No. GRN 000076. FDA, Washington.
Chung, Y.S., Lee, S.J., Choi, S.A., Lee, J.H., Ryu, J.C. and Hong, E.K. (2004) Genotoxicity study of water extract of Anemarrhena asphodeloid and Phellodendron amurense in bacterial and mammalian cell systems. Toxicol. Res., 20, 43–47.
Maron, D.M. and Ames, B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173–215.
Hong, M.Y., Kim, J.Y., Lee, Y.M. and Lee, M. (2005) Assessment of sensitivity of photo-chromosomal assay in the prediction of photo-carcinogenicity. Toxicol. Res., 21, 99–105.
Dean, B. J. and Danford, N. (1984) Assays for the detection of chemically-induced chromosome damage in cultured mammalian cells. In Mutagenicity testing - a practical approach (S. Venitt and J. M. Parry, Ed.), IRL Press Limited, Oxford, pp. 187–232.
Kirsch-Volders, M., Sofuni, T., Aardema, M., Albertini, S., Eastmond, D., Fenech, M., Ishidate, M. Jr., Kirchner, S., Lorge, E., Morita, T., Norppa, H., Surrallés, J., Vanhauwaert, A. and Wakata, A. (2003) Report from the in vitro micronucleus assay working group. Mutat. Res., 540, 153–163.
Oliver, J., Meunier, J.R., Awogi, T., Elhajouji, A., Ouldelhkim, M.C., Bichet, N., Thybaud, V., Lorenzon, G., Marzin, D. and Lorge, E. (2006) SFTG international collaborative study on in vitro micronucleus test V. Using L5178Y cells. Mutat. Res., 607, 125–152.
Fenech, M. (2000) The in vitro micronucleus technique. Mutat. Res., 455, 81–95.
Kim, J.Y., Koh, W.S. and Lee, M. (2006) Validation of photocomet assay as a model for the prediction of photocarcinogenicity. Toxicol. Res., 22, 423–429.
Schmid, W. (1975) The micronucleus test. Mutat. Res., 31, 9–15.
Richardson, C., Williams, D.A., Allen, J.A., Amphlett, G., Chanter, D.O. and Phillips, B. (1989) Analysis of data from in vitro cytogenetics assays, In : Statistical evaluation of mutagenicity test data (Kirkland, D.J. edit.), Cambridge University Press, Cambridge, pp. 141–154.
McCann, J., Horn, L. and Kaldoer, J. (1984) An evaluation of Salmonella (Ames) test data in the published literature: application of statistical procedures and analysis of mutagenicity potency. Mutat. Res., 134, 1–47.
OECD/OCDE. (1997) OECD Guidelines for the Testing of Chemicals. TG No. 471 ‘Bacterial Reverse Mutation Test’. OECD, pp. 1–11.
Lorge, E., Thybaud, V., Aardema, M.J., Oliver, J., Wakata, A., Lorenzon, G. and Marzin, D. (2006) SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. Mutat. Res., 607, 13–36.
Fenech, M. and Morley, A.A. (1985) Measurement of micronuclei in lymphocytes. Mutat. Res., 147, 29–36.
Moon, H.J., Jeya, M., Kim, I.W. and Lee, J.K. (2010) Biotechnological production of erythritol and its applications. Appl. Microbiol. Biotechnol., 86, 1017–1025.
Tandel, K.R. (2011) Sugar substitutes: Health controversy over perceived benefits. J. Pharmacol. Pharmacother., 2, 236–243.
Bryan, G.T., Ertürk, E. and Yoshida, O. (1970) Production of urinary bladder carcinomas in mice by sodium saccharin. Science, 168, 1238–1240.
Magnuson, B.A., Burdock, G.A., Doull, J., Kroes, R.M., Marsh, G.M., Pariza, M.W., Spencer, P.S., Waddell, W.J., Walker, R. and Williams, G.M. (2007) Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit. Rev. Toxicol., 37, 629–727.
Takayama, S., Sieber, S.M., Adamson, R.H., Thorgeirsson, U.P., Dalgard, D.W., Arnold, L.L., Cano, M., Eklund, S. and Cohen, M.S. (1998) Long-term feeding of sodium saccharin to nonhuman primates: implications for urinary tract cancer. J. Natl. Cancer Inst., 90, 19–25.
Whysner, J. and Williams, G.M. (1996) Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther., 71, 225–252.
Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., de Sonneville, L.M., Geha, R.S., Hertelendy, Z., Koestner, A., Leon, A.S., Liepa, G.U., McMartin, K.E., Mendenhall, C.L., Munro, I.C., Novotny, E.J., Renwick, A.G., Schiffman, S.S., Schomer, D.L., Shaywitz, B.A., Spiers, P.A., Tephly, T.R., Thomas, J.A. and Trefz, F.K. (2002) Aspartame: review of safety. Regul. Toxicol. Pharmacol., 35, S1–93.
Pezzuto, J.M., Compadre, C.M., Swanson, S.M., Nanayakkara, D. and Kinghorn, A.D. (1985) Metabolically activated steviol, the aglycone of stevioside, is mutagenic. Proc. Natl. Acad. Sci. U. S. A., 82, 2478–2482.
Benford, D.J., DiNovi, M. and Schlatter, J. (2006) Safety evaluation of certain food additives: Steviol glycosides. WHO Food Additives Series (World Health Organization Joint FAO/WHO Expert Committee on Food Additives (JECFA)), 54, 140.
Kawamura, Y., Saito, Y., Imamura, M. and Modderman, J.P. (1996) Mutagenicity studies on erythritol in bacterial reversion assay systems and in chinese hamster fibroblast cells. Regul. Toxicol. Pharmacol., 24, S261–S263.
OECD/OCDE. (2010) OECD Guidelines for the Testing of Chemicals. TG No. 487 ‘In Vitro Mammalian Cell Micronucleus Test’. OECD, pp. 1–24.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Chung, YS., Lee, M. Genotoxicity Assessment of Erythritol by Using Short-term Assay. Toxicol Res. 29, 249–255 (2013). https://doi.org/10.5487/TR.2013.29.4.249
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2013.29.4.249